索拉非尼
Sorafenib; BAY 43-9006; Sorafenib Base; Sorafenib Free Base
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
500 mg 1 g
Product Availability
In-stock
Price
$126.00
Member price
Product Availability
In-stock
Price
$188.00
Member price
Quantity
- +
Product Overview
Product Name Sorafenib; BAY 43-9006; Sorafenib Base; Sorafenib Free Base
CAS284461-73-0
FormulaC21H16ClF3N4O3
MW464.82
AppearanceWhite to off-white powder
Storage conditionDry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).
Security information
Product details

Sorafenib (BAY549085; BAY-549085; BAY439006; BAY-439006; Nexavar; SFN) an approved anticancer medication, is a potent and orally bioavailable multikinase inhibitor with potential anticancer activity (BAY549085; BAY-549085; BAY439006; BAY-439006; Nexavar; SFN). In enzymatic assays, it inhibits numerous kinases, including Raf-1, B-Raf, and VEGFR-2, with IC50 values of 6 nM, 22 nM, and 90 nM, respectively. The FDA granted sorafenib approval in 2005 to treat advanced renal cancer.

Related literature
Related
Sorry, no related items
History
Sorafenib; BAY 43-9006; Sorafenib Base; Sorafenib Free Base
Mirdametinib (PD0325901)
Lenvatinib | E7080
Amphotericin B | NSC 527017 | LNS-AmB
Siplizumab (Synonyms: MEDI-507)
Lucatumumab (Synonyms: HCD122)
Pinatuzumab (Anti-Siglec-2 / CD22)
(±)-Stylopine hydrochloride | Tetrahydrocoptisine hydrochloride
Rosin
Nigakinone